NEW YORK (GenomeWeb News) – The Cambridge, UK-based translational genomics company Horizon Discovery announced today that it has signed a non-exclusive commercial agreement with OSI Pharmaceuticals. Under the agreement, OSI will evaluate nine of Horizon’s X-MAN cell lines and matched cells with normal genetic backgrounds for 12 months, starting this month.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.